According to Spyre Therapeutics's latest financial reports the company's current earnings (TTM) are -โน14.51 B. In 2023 the company made an earning of -โน10.79 B a decrease over its 2022 earnings that were of -โน7.12 B.The earnings displayed on this page is the company's Pretax Income.